Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England of Journal of Medicine April 16, 2026
ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health April 16, 2026
It’s Time to Pass Go! MONOPOLY Big Board Bucks™ by Aristocrat Gaming™ Makes Its Official Debut at Yaamava’ Resort & Casino April 16, 2026
Artmarket.com news: Artprice confirms the success of Artprice News, the world’s first news agency entirely dedicated to art and its market, available in 11 languages and 122 countries, with Cision PR Newswire and X April 15, 2026
Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada April 13, 2026